<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36077343</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>17</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Targeting the Mitochondrial Protein VDAC1 as a Potential Therapeutic Strategy in ALS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9946</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23179946</ELocationID><Abstract><AbstractText>Impaired mitochondrial function has been proposed as a causative factor in neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), caused by motor neuron degeneration. Mutations in superoxide dismutase (SOD1) cause ALS and SOD1 mutants were shown to interact with the voltage-dependent anion channel 1 (VDAC1), affecting its normal function. VDAC1 is a multi-functional channel located at the outer mitochondrial membrane that serves as a mitochondrial gatekeeper controlling metabolic and energetic crosstalk between mitochondria and the rest of the cell and it is a key player in mitochondria-mediated apoptosis. Previously, we showed that VDAC1 interacts with SOD1 and that the VDAC1-N-terminal-derived peptide prevented mutant SOD1 cytotoxic effects. In this study, using a peptide array, we identified the SOD1 sequence that interacts with VDAC1. Synthetic peptides generated from the identified VDAC1-binding sequences in SOD1 directly interacted with purified VDAC1. We also show that VDAC1 oligomerization increased in spinal cord mitochondria isolated from mutant SOD1<sup>G93A</sup> mice and rats. Thus, we used the novel VDAC1-specific small molecules, VBIT-4 and VBIT-12, inhibiting VDAC1 oligomerization and subsequently apoptosis and associated processes such as ROS production, and increased cytosolic Ca<sup>2+</sup>. VBIT-12 was able to rescue cell death induced by mutant SOD1 in neuronal cultures. Finally, although survival was not affected, VBIT-12 administration significantly improved muscle endurance in mutant SOD1<sup>G93A</sup> mice. Therefore, VBIT-12 may represent an attractive therapy for maintaining muscle function during the progression of ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shteinfer-Kuzmine</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Life Sciences and the National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argueti-Ostrovsky</LastName><ForeName>Shirel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Faculty of Health Sciences and The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leyton-Jaimes</LastName><ForeName>Marcel F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Faculty of Health Sciences and The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Stem Cell and Regenerative Biology, Sherman Fairchild, Harvard University, 7 Divinity Ave., Cambridge, MA 02138, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anand</LastName><ForeName>Uttpal</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0001-5924-7866</Identifier><AffiliationInfo><Affiliation>Department of Life Sciences and the National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Hamad</LastName><ForeName>Salah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Faculty of Health Sciences and The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zalk</LastName><ForeName>Ran</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-4251-6497</Identifier><AffiliationInfo><Affiliation>Ilse Katz Institute for Nanoscale Science &amp; Technology, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoshan-Barmatz</LastName><ForeName>Varda</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-6756-4340</Identifier><AffiliationInfo><Affiliation>Department of Life Sciences and the National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Israelson</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8289-7653</Identifier><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Faculty of Health Sciences and The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>284/19</GrantID><Agency>Israel Science Foundation</Agency><Country/></Grant><Grant><GrantID>974/19</GrantID><Agency>Israel Science Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024101">Mitochondrial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494764">Vdac1 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.6.-</RegistryNumber><NameOfSubstance UI="D050995">Voltage-Dependent Anion Channel 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024101" MajorTopicYN="N">Mitochondrial Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050995" MajorTopicYN="N">Voltage-Dependent Anion Channel 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">VDAC1</Keyword><Keyword MajorTopicYN="N">apoptosis</Keyword><Keyword MajorTopicYN="N">misfolded proteins</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">mutant SOD1</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36077343</ArticleId><ArticleId IdType="pmc">PMC9456491</ArticleId><ArticleId IdType="doi">10.3390/ijms23179946</ArticleId><ArticleId IdType="pii">ijms23179946</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Da Cruz S., Cleveland D.W. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr. Opin. Neurobiol. 2011;21:904&#x2013;919. doi: 10.1016/j.conb.2011.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2011.05.029</ArticleId><ArticleId IdType="pmc">PMC3228892</ArticleId><ArticleId IdType="pubmed">21813273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur S.J., McKeown S.R., Rashid S. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis. Gene. 2016;577:109&#x2013;118. doi: 10.1016/j.gene.2015.11.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.11.049</ArticleId><ArticleId IdType="pubmed">26657039</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Hamad S., Kahn J., Leyton-Jaimes M.F., Rosenblatt J., Israelson A. Misfolded SOD1 Accumulation and Mitochondrial Association Contribute to the Selective Vulnerability of Motor Neurons in Familial ALS: Correlation to Human Disease. ACS Chem. Neurosci. 2017;8:2225&#x2013;2234. doi: 10.1021/acschemneuro.7b00140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.7b00140</ArticleId><ArticleId IdType="pubmed">28715630</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A., Ditsworth D., Sun S., Song S., Liang J., Hruska-Plochan M., McAlonis-Downes M., Abu-Hamad S., Zoltsman G., Shani T., et al. Macrophage Migration Inhibitory Factor as a Chaperone Inhibiting Accumulation of Misfolded SOD1. Neuron. 2015;86:218&#x2013;232. doi: 10.1016/j.neuron.2015.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.02.034</ArticleId><ArticleId IdType="pmc">PMC4393372</ArticleId><ArticleId IdType="pubmed">25801706</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E., Sandoe J., Williams L.A., Boulting G.L., Moccia R., Wainger B.J., Han S., Peng T., Thams S., Mikkilineni S., et al. Pathways Disrupted in Human ALS Motor Neurons Identified through Genetic Correction of Mutant. Cell Stem Cell. 2016;14:1934&#x2013;5909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S., Cabuy E., Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 2009;12:1097&#x2013;6256. doi: 10.1038/nn.2297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2297</ArticleId><ArticleId IdType="pubmed">19330001</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M., Kurisu J., Tsukita K., Takahashi R. Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis. J. Neurochem. 2002;83:1030&#x2013;1042. doi: 10.1046/j.1471-4159.2002.01211.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2002.01211.x</ArticleId><ArticleId IdType="pubmed">12437574</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Agar J.N., Strong M., Durham H.D. Impaired proteasome function in sporadic amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2012;13:367&#x2013;371. doi: 10.3109/17482968.2012.686511.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.686511</ArticleId><ArticleId IdType="pubmed">22632443</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E., Br&#xe4;nnstr&#xf6;m T., Andersen P.M., Marklund S.L. Low autophagy capacity implicated in motor system vulnerability to mutant superoxide dismutase. Acta Neuropathol. Commun. 2016;4:6. doi: 10.1186/s40478-016-0274-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0274-y</ArticleId><ArticleId IdType="pmc">PMC4727314</ArticleId><ArticleId IdType="pubmed">26810478</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal S.S., Cardoso I., Valentine J.S., Gomes C.M. Calcium Ions Promote Superoxide Dismutase 1 (SOD1) Aggregation into Non-fibrillar Amyloid. J. Biol. Chem. 2013;288:25219&#x2013;25228. doi: 10.1074/jbc.M113.470740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.470740</ArticleId><ArticleId IdType="pmc">PMC3757185</ArticleId><ArticleId IdType="pubmed">23861388</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber S.C., Mead R., Shaw P.J. Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target. Biochim. Biophys. Acta (BBA)&#x2014;Mol. Basis Dis. 2006;1762:1051&#x2013;1067. doi: 10.1016/j.bbadis.2006.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.03.008</ArticleId><ArticleId IdType="pubmed">16713195</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Bosch L., van Damme P., Bogaert E., Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta (BBA)&#x2014;Mol. Basis Dis. 2006;1762:1068&#x2013;1082. doi: 10.1016/j.bbadis.2006.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.05.002</ArticleId><ArticleId IdType="pubmed">16806844</ArticleId></ArticleIdList></Reference><Reference><Citation>Beretta S., Sala G., Mattavelli L., Ceresa C., Casciati A., Ferri A., Carr&#xec; M.T., Ferrarese C. Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine. Neurobiol. Dis. 2003;13:213&#x2013;221. doi: 10.1016/S0969-9961(03)00043-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0969-9961(03)00043-3</ArticleId><ArticleId IdType="pubmed">12901835</ArticleId></ArticleIdList></Reference><Reference><Citation>Velde C.V., Miller T.M., Cashman N.R., Cleveland D.W. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc. Natl. Acad. Sci. USA. 2008;105:4022&#x2013;4027. doi: 10.1073/pnas.0712209105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0712209105</ArticleId><ArticleId IdType="pmc">PMC2268797</ArticleId><ArticleId IdType="pubmed">18296640</ArticleId></ArticleIdList></Reference><Reference><Citation>Halestrap A.P., Doran E., Gillespie J.P., O&#x2019;Toole A. Mitochondria and cell death. Biochem. Soc. Trans. 2000;28:170&#x2013;177. doi: 10.1042/bst0280170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bst0280170</ArticleId><ArticleId IdType="pubmed">10816121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu. Rev. Genet. 2005;39:359&#x2013;407. doi: 10.1146/annurev.genet.39.110304.095751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.genet.39.110304.095751</ArticleId><ArticleId IdType="pmc">PMC2821041</ArticleId><ArticleId IdType="pubmed">16285865</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S., Ait-El-Mkadem S., Chaussenot A., Genin E.C., Lacas-Gervais S., Fragaki K., Berg-Alonso L., Kageyama Y., Serre V., Moore D.G., et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain. 2014;137:2329&#x2013;2345. doi: 10.1093/brain/awu138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu138</ArticleId><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Darshi M., Mendiola V.L., Mackey M.R., Murphy A.N., Koller A., Perkins G.A., Ellisman M.H., Taylor S.S. ChChd3, an inner mitochondrial membrane protein, is essential for maintaining crista integrity and mitochondrial function. J. Biol. Chem. 2011;286:2918&#x2013;2932. doi: 10.1074/jbc.M110.171975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.171975</ArticleId><ArticleId IdType="pmc">PMC3024787</ArticleId><ArticleId IdType="pubmed">21081504</ArticleId></ArticleIdList></Reference><Reference><Citation>Kholmukhamedov E.L., Czerny C., Lovelace G., Beeson K.C., Baker T., Johnson C.B., Pediaditakis P., Teplova V.V., Tikunov A., MacDonald J., et al. The role of the voltage-dependent anion channels in the outer membrane of mitochondria in the regulation of cellular metabolism. Biofizika. 2010;55:822&#x2013;833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4547860</ArticleId><ArticleId IdType="pubmed">21033348</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V., de Pinto V., Zweckstetter M., Raviv Z., Keinan N., Arbel N. VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol. Asp. Med. 2010;31:227&#x2013;285. doi: 10.1016/j.mam.2010.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2010.03.002</ArticleId><ArticleId IdType="pubmed">20346371</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V., Ben-Hail D. VDAC, a multi-functional mitochondrial protein as a pharmacological target. Mitochondrion. 2012;12:24&#x2013;34. doi: 10.1016/j.mito.2011.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2011.04.001</ArticleId><ArticleId IdType="pubmed">21530686</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V., Ben-Hail D., Admoni L., Krelin Y., Tripathi S.S. The mitochondrial voltage-dependent anion channel 1 in tumor cells. Biochim. Biophys. Acta. 2015;1848:2547&#x2013;2575. doi: 10.1016/j.bbamem.2014.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2014.10.040</ArticleId><ArticleId IdType="pubmed">25448878</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghavan A., Sheiko T., Graham B.H., Craigen W.J. Voltage-dependant anion channels: Novel insights into isoform function through genetic models. Biochim. Biophys. Acta. 2012;1818:1477&#x2013;1485. doi: 10.1016/j.bbamem.2011.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2011.10.019</ArticleId><ArticleId IdType="pmc">PMC4273737</ArticleId><ArticleId IdType="pubmed">22051019</ArticleId></ArticleIdList></Reference><Reference><Citation>de Pinto V., Guarino F., Guarnera A., Messina A., Reina S., Tomasello F.M., Palermo V., Mazzoni C. Characterization of human VDAC isoforms: A peculiar function for VDAC3? Biochim. Biophys. Acta. 2010;1797:1268&#x2013;1275. doi: 10.1016/j.bbabio.2010.01.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2010.01.031</ArticleId><ArticleId IdType="pubmed">20138821</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V., Maldonado E.N., Krelin Y. VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress. Cell Stress. 2017;1:11&#x2013;36. doi: 10.15698/cst2017.10.104.</Citation><ArticleIdList><ArticleId IdType="doi">10.15698/cst2017.10.104</ArticleId><ArticleId IdType="pmc">PMC6287957</ArticleId><ArticleId IdType="pubmed">30542671</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V., Mizrachi D., Keinan N. Oligomerization of the mitochondrial protein VDAC1: From structure to function and cancer therapy. Prog. Mol. Biol. Transl. Sci. 2013;117:303&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pubmed">23663973</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646&#x2013;674. doi: 10.1016/j.cell.2011.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.02.013</ArticleId><ArticleId IdType="pubmed">21376230</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V., Israelson A., Brdiczka D., Sheu S.S. The Voltage-Dependent Anion Channel (VDAC): Function in Intracellular Signalling, Cell Life and Cell Death. Curr. Pharm. Des. 2006;12:2249&#x2013;2270. doi: 10.2174/138161206777585111.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161206777585111</ArticleId><ArticleId IdType="pubmed">16787253</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V., Golan M. Mitochondrial VDAC1: Function in cell life and death and a target for cancer therapy. Curr. Med. Chem. 2012;19:714&#x2013;735. doi: 10.2174/092986712798992110.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986712798992110</ArticleId><ArticleId IdType="pubmed">22204343</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V., Mizrachi D. VDAC1: From structure to cancer therapy. Front. Oncol. 2012;2:164. doi: 10.3389/fonc.2012.00164.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2012.00164</ArticleId><ArticleId IdType="pmc">PMC3516065</ArticleId><ArticleId IdType="pubmed">23233904</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A., Arbel N., da Cruz S., Ilieva H., Yamanaka K., Shoshan-Barmatz V., Cleveland D.W. Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALS. Neuron. 2010;67:575&#x2013;587. doi: 10.1016/j.neuron.2010.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.07.019</ArticleId><ArticleId IdType="pmc">PMC2941987</ArticleId><ArticleId IdType="pubmed">20797535</ArticleId></ArticleIdList></Reference><Reference><Citation>Shteinfer-Kuzmine A., Argueti S., Gupta R., Shvil N., Abu-Hamad S., Gropper Y., Hoeber J., Magr&#xec; A., Messina A., Kozlova E.N., et al. A VDAC1-Derived N-Terminal Peptide Inhibits Mutant SOD1-VDAC1 Interactions and Toxicity in the SOD1 Model of ALS. Front. Cell Neurosci. 2019;13:346. doi: 10.3389/fncel.2019.00346.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00346</ArticleId><ArticleId IdType="pmc">PMC6702328</ArticleId><ArticleId IdType="pubmed">31474832</ArticleId></ArticleIdList></Reference><Reference><Citation>Pittala M.G.G., Reina S., Cubisino S.A.M., Cucina A., Formicola B., Cunsolo V., Foti S., Saletti R., Messina A. Post-Translational Modification Analysis of VDAC1 in ALS-SOD1 Model Cells Reveals Specific Asparagine and Glutamine Deamidation. Antioxidants. 2020;9:1218. doi: 10.3390/antiox9121218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9121218</ArticleId><ArticleId IdType="pmc">PMC7761621</ArticleId><ArticleId IdType="pubmed">33276691</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V., Shteinfer-Kuzmine A., Verma A. VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases. Biomolecules. 2020;10:1485. doi: 10.3390/biom10111485.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10111485</ArticleId><ArticleId IdType="pmc">PMC7693975</ArticleId><ArticleId IdType="pubmed">33114780</ArticleId></ArticleIdList></Reference><Reference><Citation>Arif T., Krelin Y., Nakdimon I., Benharroch D., Paul A., Dadon-Klein D., Shoshan-Barmatz V. VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties. Neuro Oncol. 2017;19:951&#x2013;964. doi: 10.1093/neuonc/now297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuonc/now297</ArticleId><ArticleId IdType="pmc">PMC5570220</ArticleId><ArticleId IdType="pubmed">28339833</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V., Krelin Y., Shteinfer-Kuzmine A., Arif T. Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics. Front. Oncol. 2017;7:154. doi: 10.3389/fonc.2017.00154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2017.00154</ArticleId><ArticleId IdType="pmc">PMC5534932</ArticleId><ArticleId IdType="pubmed">28824871</ArticleId></ArticleIdList></Reference><Reference><Citation>Arif T., Vasilkovsky L., Refaely Y., Konson A., Shoshan-Barmatz V. Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo, Molecular therapy. Nucleic Acids. 2014;3:e159. doi: 10.1038/mtna.2014.9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mtna.2014.9</ArticleId><ArticleId IdType="pmc">PMC4011124</ArticleId><ArticleId IdType="pubmed">24781191</ArticleId></ArticleIdList></Reference><Reference><Citation>Manczak M., Reddy P.H. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer&#x2019;s disease. Hum. Mol. Genet. 2012;21:5131&#x2013;5146. doi: 10.1093/hmg/dds360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds360</ArticleId><ArticleId IdType="pmc">PMC3490521</ArticleId><ArticleId IdType="pubmed">22926141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuadrado-Tejedor M., Vilarino M., Cabodevilla F., del Rio J., Frechilla D., Perez-Mediavilla A. Enhanced expression of the voltage-dependent anion channel 1 (VDAC1) in Alzheimer&#x2019;s disease transgenic mice: An insight into the pathogenic effects of amyloid-beta. J. Alzheimer&#x2019;s Dis. JAD. 2011;23:195&#x2013;206. doi: 10.3233/JAD-2010-100966.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-100966</ArticleId><ArticleId IdType="pubmed">20930307</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Gracia E., Torrejon-Escribano B., Ferrer I. Dystrophic neurites of senile plaques in Alzheimer&#x2019;s disease are deficient in cytochrome c oxidase. Acta Neuropathol. 2008;116:261&#x2013;268. doi: 10.1007/s00401-008-0370-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0370-6</ArticleId><ArticleId IdType="pubmed">18629521</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed M., Muhammed S.J., Kessler B., Salehi A. Mitochondrial proteome analysis reveals altered expression of voltage dependent anion channels in pancreatic beta-cells exposed to high glucose. Islets. 2010;2:283&#x2013;292. doi: 10.4161/isl.2.5.12639.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/isl.2.5.12639</ArticleId><ArticleId IdType="pubmed">21099326</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong D., Chen X., Middleditch M., Huang L., Amarsingh G.V., Reddy S., Lu J., Zhang S., Ruggiero K., Phillips A.R., et al. Quantitative proteomic profiling identifies new renal targets of copper(II)-selective chelation in the reversal of diabetic nephropathy in rats. Proteomics. 2009;9:4309&#x2013;4320. doi: 10.1002/pmic.200900285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.200900285</ArticleId><ArticleId IdType="pubmed">19634143</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang E., Mohammed Al-Amily I., Mohammed S., Luan C., Asplund O., Ahmed M., Ye Y., Ben-Hail D., Soni A., Vishnu N., et al. Preserving Insulin Secretion in Diabetes by Inhibiting VDAC1 Overexpression and Surface Translocation in &#x3b2; Cells. Cell Metab. 2019;29:64&#x2013;77. doi: 10.1016/j.cmet.2018.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2018.09.008</ArticleId><ArticleId IdType="pmc">PMC6331340</ArticleId><ArticleId IdType="pubmed">30293774</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Gupta R., Blanco L.P., Yang S., Shteinfer-Kuzmine A., Wang K., Zhu J., Kang K., Zhu X., Park S.-J., et al. VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease. Science. 2019;366:1531&#x2013;1536. doi: 10.1126/science.aav4011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav4011</ArticleId><ArticleId IdType="pmc">PMC8325171</ArticleId><ArticleId IdType="pubmed">31857488</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A., Pittala S., Alhozeel B., Shteinfer-Kuzmine A., Ohana E., Gupta R., Chung J.H., Shoshan-Barmatz V. The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: A potential therapeutic target. Mol. Ther. 2021;30:726&#x2013;744. doi: 10.1016/j.ymthe.2021.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2021.06.024</ArticleId><ArticleId IdType="pmc">PMC8821898</ArticleId><ArticleId IdType="pubmed">34217890</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Hamad S., Zaid H., Israelson A., Nahon E., Shoshan-Barmatz V. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: Mapping the site of binding. J. Biol. Chem. 2008;283:13482&#x2013;13490. doi: 10.1074/jbc.M708216200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M708216200</ArticleId><ArticleId IdType="pubmed">18308720</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilansky A., Dangoor L., Nakdimon I., Ben-Hail D., Mizrachi D., Shoshan-Barmatz V. The Voltage-dependent Anion Channel 1 Mediates Amyloid beta Toxicity and Represents a Potential Target for Alzheimer Disease Therapy. J. Biol. Chem. 2015;290:30670&#x2013;30683. doi: 10.1074/jbc.M115.691493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.691493</ArticleId><ArticleId IdType="pmc">PMC4692199</ArticleId><ArticleId IdType="pubmed">26542804</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaid H., Abu-Hamad S., Israelson A., Nathan I., Shoshan-Barmatz V. The voltage-dependent anion channel-1 modulates apoptotic cell death. Cell Death Differ. 2005;12:751&#x2013;760. doi: 10.1038/sj.cdd.4401599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cdd.4401599</ArticleId><ArticleId IdType="pubmed">15818409</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Hail D., Begas-Shvartz R., Shalev M., Shteinfer-Kuzmine A., Gruzman A., Reina S., de Pinto V., Shoshan-Barmatz V. Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction. J. Biol. Chem. 2016;291:24986&#x2013;25003. doi: 10.1074/jbc.M116.744284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.744284</ArticleId><ArticleId IdType="pmc">PMC5122769</ArticleId><ArticleId IdType="pubmed">27738100</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera--a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605&#x2013;1612. doi: 10.1002/jcc.20084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20084</ArticleId><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference><Reference><Citation>Zalk R., Israelson A., Garty E.S., Azoulay-Zohar H., Shoshan-Barmatz V. Oligomeric states of the voltage-dependent anion channel and cytochrome c release from mitochondria. Biochem. J. 2005;386:73&#x2013;83. doi: 10.1042/BJ20041356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20041356</ArticleId><ArticleId IdType="pmc">PMC1134768</ArticleId><ArticleId IdType="pubmed">15456403</ArticleId></ArticleIdList></Reference><Reference><Citation>Keinan N., Tyomkin D., Shoshan-Barmatz V. Oligomerization of the mitochondrial protein voltage-dependent anion channel is coupled to the induction of apoptosis. Mol. Cell. Biol. 2010;30:5698&#x2013;5709. doi: 10.1128/MCB.00165-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00165-10</ArticleId><ArticleId IdType="pmc">PMC3004265</ArticleId><ArticleId IdType="pubmed">20937774</ArticleId></ArticleIdList></Reference><Reference><Citation>Keinan N., Pahima H., Ben-Hail D., Shoshan-Barmatz V. The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis. Biochim. Biophys. Acta. 2013;1833:1745&#x2013;1754. doi: 10.1016/j.bbamcr.2013.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2013.03.017</ArticleId><ArticleId IdType="pubmed">23542128</ArticleId></ArticleIdList></Reference><Reference><Citation>di Bartolomeo F., Wagner A., Daum G. Cell biology, physiology and enzymology of phosphatidylserine decarboxylase. Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 2017;1862:25&#x2013;38. doi: 10.1016/j.bbalip.2016.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2016.09.007</ArticleId><ArticleId IdType="pubmed">27650064</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Velde C.V., Israelson A., Xie J., Bailey A.O., Dong M.Q., Chun S.J., Roy T., Winer L., Yates J.R., et al. ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc. Natl. Acad. Sci. USA. 2010;107:21146&#x2013;21151. doi: 10.1073/pnas.1014862107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1014862107</ArticleId><ArticleId IdType="pmc">PMC3000256</ArticleId><ArticleId IdType="pubmed">21078990</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H., Zhou Q., He J., Jiang Z., Peng C., Tong R., Shi J. Recent advances in the development of protein-protein interactions modulators: Mechanisms and clinical trials. Signal Transduct. Target. Ther. 2020;5:213. doi: 10.1038/s41392-020-00315-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00315-3</ArticleId><ArticleId IdType="pmc">PMC7511340</ArticleId><ArticleId IdType="pubmed">32968059</ArticleId></ArticleIdList></Reference><Reference><Citation>da Cruz S., Parone P.A., Lopes V.S., Lillo C., McAlonis-Downes M., Lee S.K., Vetto A.P., Petrosyan S., Marsala M., Murphy A.N., et al. Elevated PGC-1alpha activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Cell Metab. 2012;15:778&#x2013;786. doi: 10.1016/j.cmet.2012.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2012.03.019</ArticleId><ArticleId IdType="pmc">PMC3565468</ArticleId><ArticleId IdType="pubmed">22560226</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C.H., Davidson S., Harapas C.R., Hilton J.B., Mlodzianoski M.J., Laohamonthonkul P., Louis C., Low R.R.J., Moecking J., de Nardo D., et al. TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. Cell. 2020;183:636&#x2013;649.e18. doi: 10.1016/j.cell.2020.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.020</ArticleId><ArticleId IdType="pmc">PMC7599077</ArticleId><ArticleId IdType="pubmed">33031745</ArticleId></ArticleIdList></Reference><Reference><Citation>Shvil N., Banerjee V., Zoltsman G., Shani T., Kahn J., Abu-Hamad S., Papo N., Engel S., Bernhagen J., Israelson A. MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: Implications for familial ALS. Cell Death Dis. 2018;9:107. doi: 10.1038/s41419-017-0130-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0130-4</ArticleId><ArticleId IdType="pmc">PMC5833700</ArticleId><ArticleId IdType="pubmed">29371591</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>